Influence of Formulation Factors on Tablet Formulations with Liquid Permeation Enhancer Using Factorial Design

被引:10
作者
Bejugam, Naveen K. [1 ]
Parish, Helen J. [1 ]
Shankar, Gita N. [1 ]
机构
[1] SRI Int, Biosci Div, Pharmaceut Sci, Menlo Pk, CA 94025 USA
基金
美国国家卫生研究院;
关键词
Eudragit L 100-55; factorial design; Labrasol; Methocel K100M; tablet; IN-VITRO; METHACRYLIC-ACID; DOSAGE FORM; RELEASE; DRUG; ABSORPTION; DISSOLUTION; GENTAMICIN; LABRASOL; BIOAVAILABILITY;
D O I
10.1208/s12249-009-9345-8
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
For a drug with low bioavailability, a matrix tablet with liquid permeation enhancer (LabrasolA (R)) was formulated. Factorial design was used to evaluate the effect of three formulation factors: drug percentage, polymer type (MethocelA (R) K100M or EudragitA (R) L 100-55), and tablet binder percentage (PlasdoneA (R) S-630) on tablet characteristics. Tablets were prepared by direct compression and characterized. Compressibility index values ranged between 15.90% and 29.87% and tablet hardness values from 7.8 to 29.78 Kp. EudragitA (R)-containing formulations had better compressibility index values with higher tablet hardness. Time for 75% of drug release (T (75)) was calculated, and formulations containing EudragitA (R) L 100-55 had faster release rates than tablet formulations with MethocelA (R) K100M. Formulations with MethocelA (R) K100M fit well in the Higuchi model as indicated by their R (2) values (> 0.98). Among all the formulation factors studied, polymer type displayed the highest and statistically significant effect on compressibility index, tablet hardness, and dissolution rate. Statistical design helped in better understanding the effect of formulation factors on tablet characteristics important for designing formulations with desired characteristics.
引用
收藏
页码:1437 / 1443
页数:7
相关论文
共 39 条
[1]
Akin-Ajani OD, 2005, AAPS PHARMSCITECH, V6
[2]
A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]
AQUEOUS ACIDIC DEGRADATION OF THE CARBACEPHALOSPORIN LORACARBEF [J].
SKIBIC, MJ ;
TAYLOR, KW ;
OCCOLOWITZ, JL ;
COLLINS, MW ;
PASCHAL, JW ;
LORENZ, LJ ;
SPANGLE, LA ;
DORMAN, DE ;
BAERTSCHI, SW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (10) :1010-1017
[4]
*CAB CORP, 2006, UNTR FUM SIL CAB O S
[5]
INTRADUODENAL ABSORPTION OF THE NEW UF- HEPARIN SALT ITF 1057 IN THE CONSCIOUS DOG [J].
CARAMAZZA, I ;
DATRI, G ;
BOSSI, ML ;
DEPONTI, F ;
DANGELO, L ;
CREMA, A .
THROMBOSIS RESEARCH, 1991, 62 (06) :785-789
[6]
Carr R.L., 1965, Chem. Eng, V72, P163, DOI DOI 10.1016/J.JAEROSCI.2007.10.003
[7]
Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[8]
Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug [J].
Djordjevic, L ;
Primorac, M ;
Stupar, M ;
Krajisnik, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 271 (1-2) :11-19
[9]
Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride [J].
Gambhire, Manoj N. ;
Ambade, Kshitij W. ;
Kurmi, Sushma D. ;
Kadam, Vilasrao J. ;
Jadhav, Kisan R. .
AAPS PHARMSCITECH, 2007, 8 (03)
[10]
Fluid bed granulation of a poorly water soluble, low density, micronized drug: comparison with high shear granulation [J].
Gao, JZH ;
Jain, A ;
Motheram, R ;
Gray, DB ;
Hussain, MA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) :1-14